Create Alert
Watchlist

Aurobindo Pharma

₹1,225.10
+15.80 (1.31%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,214.00
Prev. Close
1,209.30
Volume
13,96,499
Total traded value
171 Cr
Upper Circuit
1,347.60
Lower Circuit
1,102.60

Fundamentals

Market Cap₹71,134Cr
ROE9.77%
P/E Ratio(TTM)20.79
EPS(TTM)58.90
P/B Ratio2.03
Dividend Yield0.00%
Industry P/E33.07
Book Value603.32
Debt to Equity0.22
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aurobindo Pharma

Aurobindo Pharma is a well-integrated global pharmaceutical firm committed to providing affordable and accessible medicines to patients around the globe. The company's vision is to become a leading and admired global pharmaceutical player, aiming to be ranked within the top 25 companies by the year 2030. Its mission focuses on being the most valued partner to the pharma industry by continuously developing and manufacturing products that meet the highest regulatory standards. The company develops and commercializes a diverse portfolio including generics, specialty products, injectables, active pharmaceutical ingredients, biosimilars, and vaccines across 150+ countries. Leveraging its expertise in large-scale production, the company has positioned itself as a cost-effective provider of Active Pharmaceutical Ingredients (API) for its own and external needs. As the 2nd largest listed Indian pharma company by revenue from operations, it has successfully established itself as a key player in the global market.;
Parent OrganisationAurobindo Pharma Limited
Managing DirectorK. Nithyananda Reddy
Founded1986
NSE SymbolAUROPHARMA

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
51.82%
Mutual Funds
19.30%
Foreign Institutions
14.21%
Other Domestic Institutions
8.30%
Retail And Others
6.38%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
39.93
Cipla
NA
(0.00%)
22.55
Dr Reddy's Laboratories
NA
(0.00%)
18.60
Lupin
NA
(0.00%)
22.34
2025
5
Nov
Quarterly Result
Release date

8
Aug
Dividend
Ex date
₹4.00
per share

For each share you hold, you will receive ₹4.00
Dividend amount₹4.00 per share
Dividend TypeInterim
Ex Date8 Aug ‘25
Record Date8 Aug ‘25
Announcement date4 Aug ‘25

4
Aug
Dividend
Announced
₹4.00
per share

For each share you hold, you will receive ₹4.00
Dividend amount₹4.00 per share
Dividend TypeInterim
Ex Date8 Aug ‘25
Record Date8 Aug ‘25
Announcement date4 Aug ‘25
4
Aug
Quarterly Result
Release date
26
May
Annual Result
Release date
6
Feb
Quarterly Result
Release date
2024
9
Nov
Quarterly Result
Release date
10
Aug
Quarterly Result
Release date

30
Jul
Buyback
Ex date

Offer price₹1,460.00
Buyback window5 Aug ‘24 to 9 Aug ‘24
Ex date30 Jul ‘24
Record date30 Jul ‘24
Announcement date18 Jul ‘24
Buyback typeTender Offer

18
Jul
Buyback
Announced

Offer price₹1,460.00
Buyback window5 Aug ‘24 to 9 Aug ‘24
Ex date30 Jul ‘24
Record date30 Jul ‘24
Announcement date18 Jul ‘24
Buyback typeTender Offer
25
May
Result
Release date

20
Feb
Dividend
Ex date
₹1.50
per share

For each share you hold, you will receive ₹1.50
Dividend amount₹1.50 per share
Dividend TypeInterim 2
Ex Date20 Feb ‘24
Record Date20 Feb ‘24
Announcement date10 Feb ‘24

10
Feb
Dividend
Announced
₹1.50
per share

For each share you hold, you will receive ₹1.50
Dividend amount₹1.50 per share
Dividend TypeInterim 2
Ex Date20 Feb ‘24
Record Date20 Feb ‘24
Announcement date10 Feb ‘24
Events calendar
View upcoming events in other stocks